Dr. Thanendrarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
# Slot
Little Rock, AR 72205Phone+1 501-526-6990Fax+1 501-526-2273
Education & Training
- Ruhr - University Bochum Faculty of MedicineClass of 2006
Certifications & Licensure
- AR State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 54 citationsClinical value of molecular subtyping multiple myeloma using gene expression profiling.Niels Weinhold, Christoph Heuck, Adam Z. Rosenthal, Sharmilan Thanendrarajan, Caleb K. Stein
Leukemia. 2016-02-01 - 20 citationsMonitoring treatment response and disease progression in myeloma with circulating cell-free DNA.Shayu Deshpande, Ruslana Tytarenko, Yan Wang, Eileen M Boyle, Cody Ashby
European Journal of Haematology. 2021-02-01 - 255 citationsSpatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingLeo Rasche, Shweta S. Chavan, Owen W. Stephens, Purvi Patel, Ruslana Tytarenko
Nature Communications. 2017-08-16
Journal Articles
- Mesenchymal Stem Cells Gene Signature in High‐Risk Myeloma Bone Marrow Linked to Suppression of Distinct IGFBP2‐Expressing Small AdipocytesBart Barlogie, Sharmilan Thanendrarajan, Carolina Schinke, British Journal of Haematology
Abstracts/Posters
- The Role of PHF19 As a Promoter of Tumorigenicity and Therapeutic Target in Multiple MyelomaSharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Translational Switch of MYC Protein Aliases in Myeloma Tumor CellsSharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Translational Switch of MYC Protein Aliases in Myeloma Tumor CellsSharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Proliferation and Molecular Risk Score of Low Risk Myeloma Cells Are Increased in High Risk Microenvironment Via Augmented Bioavailability of Growth Factors2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Long-Term Follow-up Identifies Double Hit and Key Mutations As Impacting Progression Free and Overall Survival in Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Extracting Prognostic Molecular Information from PET-CT Imaging of Multiple Myeloma Using Radiomic Approaches2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: